The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade

EMBO Journal

Volumn 15, Issue 18, 1996, Pages 4919-4927

  Davis Smyth, Terri ^a   Chen, Helen ^a   Park, Jeanie ^a   Presta, Leonard G ^a   Ferrara, Napoleone ^a  

^a GENENTECH INC   (United States)

Author keywords

Angiogenesis; fms like tyrosine kinase; Placenta growth factor; Signal transduction; Vascular endothelial growth factor

Indexed keywords

GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; HUMAN; LIGAND BINDING; MITOGENESIS; MORPHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

EID: 0029790466     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00872.x     Document Type: Article

References (50)

1. Aiello, L.P. et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med., 331, 1480-1487.
2. Aiello, L.P., Pierce, E.A., Foley, E.D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G.L. and Smith, L.E.H. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl Acad. Sci. USA, 92, 10457-10461.
3. Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A. and Marmé, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 87, 3336-3343.
4. Blechman, J.M., Lev, S., Barg, J., Eisenstein, M., Vaks, B., Vogel, Z., Givol, D. and Yarden, Y. (1995) The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell, 80, 103-113.
5. Capon, D.J. et al. (1989) Designing CD4 immunoadhesins for AIDS therapy. Nature, 337, 525-531.
6. Carmeliet, P. et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439.
7. de Vries, C., Escobedo, J.A., Ueno, H., Houck, K.A., Ferrara, N. and Williams, L.T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991.
8. Fantl, W.J., Johnson, D.E. and Williams, L.T. (1993) Signalling by receptor tyrosine kinases. Annu. Rev. Biochem., 62, 453-481.
9. Ferrara, N. (1993) Vascular endothelial growth factor. Trends Cardiovasc. Med., 3, 244-250.
10. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J. and Moore, M.W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-442.
11. Finnerty, H. et al. (1993) Molecular cloning of murine FLT and FLT4. Oncogene, 8, 2293-2298.
12. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31.
13. Fong, G.-H., Rossant, J., Gertsenstein, M. and Breitman, M.L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature, 376, 66-70.
14. Galland, F., Karamysheva, A., Pebusque, M.-J., Borg, J.-P., Rottapel, R., Dubreuil, P., Rosnet, O. and Birnbaum, D. (1993) The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene, 8, 1233-1240.
15. Heidaran, M.A., Pierce, J.H., Jensen, R.A., Matsui, T. and Aaronson, S.A. (1990) Chimeric α and β-platelet derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the α-PDGF receptor that determine PDGF-AA binding specitity. J. Biol. Chem., 265, 18741-18744.
16. Heidaran, M.A., Mahadevan, D. and LaRochelle, W.J. (1995) β PDGFR-IgG chimera demonstrates that human β PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding. FASEB J., 9, 140-145.
17. Heldin, C.-H. (1995) Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223.
18. Jakeman, L.B., Winer, J., Bennett, G.L., Altar, C.A. and Ferrara, N. (1992) Binding sites for vascular endothelial growth factor are localized on endothelial cells on adult rat tissue. J. Clin. Invest., 89, 244-253.
19. Jakeman, L.B., Armanini, M., Phillips, H.S. and Ferrara, N. (1993) Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology, 133, 848-859.
20. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. and Alitalo, K. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15, 290-298.
21. Keyt, B.A., Nguyen, H.V., Berleau, L.T., Duarte, C.M., Park, J., Chen, H. and Ferrara, N. (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J. Biol. Chem., 271, 5638-5646.
22. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844.
23. Kunkle, T.A. (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA, 82, 488-492.
24. Lee, J., Gray, A., Yuan, J., Luoh, S.-M., Avraham, H. and Wood, W.I. (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl Acad. Sci. USA, 93, 1988-1992.
25. Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P. and Persico, M.G. (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl Acad. Sci. USA, 88, 9267-9271.
26. Mahadevan, D., Yu, J.-C., Saldanha, J.W., Thanki, N., McPhie, P., Uren, A., LaRochelle, W.J. and Heidaran, M.A. (1995) Structural role of extracellular domain 1 of α-platelet-derived growth factor (PDGF) receptor for PDGF-AA and PDGF-BB binding. J. Biol. Chem., 270, 27595-27600.
27. Matthews, W., Jordan, C.T., Gavin, M., Jenkins, N.A., Copeland, N.G. and Lemischka, I.R. (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl Acad. Sci. USA, 88, 9026-9030.
28. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N.P.H., Risau, W. and Ullrich, A. (1993) High affinity binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846.
29. Millauer, B., Shawver, L.K., Plate, K.H., Risau, W. and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature, 367, 576-579.
30. Mustonen, T. and Alitalo, K. (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol., 129, 895-898.
31. Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R. and Alitalo, K. (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res., 52, 5738-5743.
32. Pajusola, K., Aprelikova, O., Pelicci, G., Weich, H., Claesson-Welsh, L. and Alitalo, K. (1994) Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene, 9, 3545-3555.
33. Park, J.E., Chen, H.H., Winer, J., Houck, K.A. and Ferrara, N. (1994) Placenta growth factor. Potentiation of vascular growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem., 269, 25646-25654.
34. Pearlman, J.D., Hibberd, M.G., Chuang, M.L., Harada, K., Lopez, J.J., Gladstone, S.R., Friedman, M., Sellke, F.W. and Simons, M. (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med., 1, 1085-1089.
35. Peters, K.G., De Vries, C. and Williams, L.T. (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl Acad. Sci. USA, 90, 8915-8919.
36. Quinn, T. Peters, K.G., de Vries, C., Ferrara, N. and Williams, L.T. (1993) Fetal liver kinase is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl Acad. Sci. USA, 90, 7533-7537.
37. Schneider, R. and Schweiger, M. (1991) A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trkB tyrosine kinase receptors. Oncogene, 6, 1807-1811.
38. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S. and Shibuya, M. (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 10, 135-147.
39. Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X., Breitman, M.L. and Schuh, A.C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 376, 62-66.
40. Shibuya, M. (1995) Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv. Cancer Res., 67, 281-316.
41. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H. and Sato, M. (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene, 8, 519-527.
42. Su, W., Middleton, T., Sudgen, B. and Echols, H. (1991) DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc. Natl Acad. Sci. USA, 88, 10870-10874.
43. Takeshita, S., Zhung, L., Brogi, E., Kearney, M., Pu, L.-Q., Bunting, S., Ferrara, N., Symes, J.F. and Isner, J.M. (1994) Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest., 93, 662-670.
44. Terman, B.I., Carrion, M.E., Kovacs, E., Rasmussen, B.A., Eddy, R.L. and Shows, T.B. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene, 6, 1677-1683.
45. Terman, B.I., Dougher-Vermazen, M., Carrion, M.E., Dimitrov, D., Armellino, D.C., Gospodarowicz, D. and Böhlen, P. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res Commun., 34, 1578-1586.
46. Ullrich, A. and Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
47. Urfer, R., Tsoulfas, P., O'Connell, L., Shelton, D.L., Parada, L.F. and Presta, L. (1995) An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J., 14, 2795-2805.
48. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. and Heldin, C. (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269, 26988-26995.
49. Williams, A.F. and Barclay, A.N. (1988) The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol., 6, 381-405.
50. Yarden, Y. and Ullrich, A. (1988) Growth factor receptor tyrosine kinases. Annu. Rev. Biochem., 57, 443-478.